Skip to main content

A worldwide technology outage is causing disruption to some State of Illinois online systems. We are aware of this issue and are diligently working on restoration.

Notice of Privacy Incident
We are offering two in-person Healthchoice Illinois Listening Sessions allow you the opportunity to talk about your experiences with HealthChoice Illinois managed care. Please be sure to register for one of these important events.

Drugs and Therapeutics (D & T) Committee Drugs Under Review for: September 17, 2014

Drug Name	Review Type	Class	Manufacturer
Otezla	New Drug Initial Review	Phosphodiesterase 4 Inhibitor	Celgene
Hemangeol	New Drug Initial Review	Beta-Adrenergic Blocker	Pierre Fabre
Opsumit	New Drug Initial Review	Pulmonary Aterial Hypertension	Actelion
Orenitram ER	New Drug Initial Review	Pulmonary Aterial Hypertension	United Therapeutics
Mycamine	New Drug Initial Review	Anti-fungal	Astellas
Ambisome	New Drug Initial Review	Anti-fungal	Astellas
Brilinta	PDL Appeal	Platelet Aggregation Inhibitor	Astra Zeneca